Clinipace Worldwide

Pharma

N.C. CRO Clinipace names new chief medical officer for Europe

North Carolina clinical research organization Clinipace Worldwide is flexing its muscles abroad with an executive hire that boosts the CRO’s European operations. Dr. Jurgen Frisch has been named chief medical officer for Clinipace’s European operations. He will be based in the company’s offices in Zurich, Switzerland. Clinipace, headquartered in Morrisville, North Carolina, has experienced considerable […]

News

N.C. CRO Clinipace raises $15M, aims to build its global reach

North Carolina clinical research organization Clinipace Worldwide has closed a $15 million round of funding that the company will use to build its global capacity. Morgan Stanley Expansion Capital led the series C round, joined by existing investors Hatteras Venture Partners and Brook Private Equity Advisors. Morrisville, North Carolina-based Clinipace owes much of its global […]

News

Clinipace acquires Swiss firm PFC to build global CRO presence

Clinical research organization Clinipace Worldwide has acquired Swiss company PFC Pharma Focus in a move that extends Clinipace’s global presence. The acquisition is the third in 18 months and the second this year for Morrisville, North Carolina-based Clinipace. Financial terms were not disclosed. Zurich, Switzerland-based PFC has offices in Germany, Israel and India. The CRO […]

News

CRO Clinipace raises $8M; M&A announcement expected

Clinical research organization Clinipace Worldwide has raised more than $8 million in financing and the company is preparing for an announcement about the funding. A  spokeswoman for Morrisville, North Carolina-based Clinipace said the company is not commenting on the financing until a planned announcement next Wednesday. But the announcement is expected to be an acquisition. […]